Table 1.
Basic characteristics of papers analyzed
| First author, [Reference] | Country | Prescribed dose, Gy |
Sample size |
Organs at risk | Level of the dose, Gy | |
|---|---|---|---|---|---|---|
| IMRT* | 3D-CRT+ | |||||
| Heron DE [26] |
USA |
45 |
10 |
10 |
Rectum, Small bowel, Bladder |
10, 20, 30, 40, 45 |
| Chen MF [36] |
Taiwan |
50.4 |
33 |
35 |
Rectum, Small bowel, Bladder, Bone marrow |
5, 10, 15, 20, 25, 30, 35, 40, 45 |
| Mell LK [30] |
USA |
45 |
7 |
7 |
Rectum, Small bowel, Bladder, Bone marrow |
5, 10, 20, 30, 40, 45 |
| Igdem S [31] |
Turkey |
45 or 50.4 |
10 |
10 |
Rectum, Small bowel, Bladder, Bone marrow |
5, 10, 15, 20, 25, 30, 40, 45 |
| Roeske JC [37] |
USA |
45 |
10 |
10 |
Rectum, Small bowel, Bladder |
5, 10, 15, 20, 25, 30, 35, 40, 45 |
| Portelance L [17] |
USA |
45 |
10 |
10 |
Rectum, Small bowel, Bladder |
45 |
| Lujan AE [38] |
USA |
45 |
10 |
10 |
Bone marrow |
5, 10, 15, 20, 25, 30, 35, 40, 45 |
| Brixey CJ [39] |
USA |
45 |
36 |
88 |
Iliac crest, Lumbar spine, Sacrum |
5, 10, 15, 20, 25, 30, 35, 40, 45 |
| Ahmed RS [27] |
USA |
45 |
5 |
5 |
Bone marrow |
5, 10, 15, 20, 25, 30, 35, 40, 45 |
| Mell LK [37] |
USA |
45 |
37 |
0 |
Bone marrow |
10, 20, 30, 40 |
| Mundt AJ [38] |
USA |
45 |
36 |
30 |
Small bowel |
5, 10, 15, 20, 25, 30, 35, 40, 45 |
| Salama JK [40] |
USA |
45 |
13 |
13 |
Rectum, Small bowel |
5, 10, 15, 20, 25, 30, 35, 40, 45 |
| Georg D [41] | Austria | 50.4 | 5 | 5 | Rectum, Small bowel, Bladder | 5, 10, 15, 20, 25, 30, 35, 40, 45 |
* intensity modulated radiotherapy; + three-dimensional conformal radiotherapy.